Cognitive effects from topiramate include difficulty concentrating and memory problems in 6% of users
Nrby-Rasmussen, S
Others titrate too quickly, developing side effects that force dose reductions
In the UK, it is being reviewed by the Medicines and Healthcare products Regulatory Agency, possibly making it available for private prescription in late 2026/early 2027 if it gets the go-ahead
a , GLP-1R (WT), b , GLP-1R triple mutant (L142A, K202A, Y145A), c , GLP-1R (K202A), d , GLP-1R (Y145A), e , GLP-1R (Y145F)
Availability & Supply Chain When will the Ozempic and Wegovy shortages officially end